PROCEPT BioRobotics Corporation

PRCT
$29.09 (+ $0.31 + 1.08%)
Last updated: 2026-06-11 04:04 UTC
PRCT Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryMedical Devices
ISINUS74276L1052
CUSIP74276L105
Market Price29.09
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.54
Market Cap$1.8B
Book Value6.81
Price to Book4.831
Beta0.99
52w High89.49
52w Low27.8
Next Earnings DateN/A

PROCEPT BioRobotics Corporation trades under ticker PRCT on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US74276L1052, CUSIP 74276L105.

About the Company
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Price History